Amh Equity LTD Scynexis Inc Transaction History
Amh Equity LTD
- $72.3 Million
- Q3 2024
A detailed history of Amh Equity LTD transactions in Scynexis Inc stock. As of the latest transaction made, Amh Equity LTD holds 600,000 shares of SCYX stock, worth $600,000. This represents 1.24% of its overall portfolio holdings.
Number of Shares
600,000
Previous 545,000
10.09%
Holding current value
$600,000
Previous $1.09 Million
17.98%
% of portfolio
1.24%
Previous 1.52%
Shares
6 transactions
Others Institutions Holding SCYX
# of Institutions
48Shares Held
13.7MCall Options Held
21.9KPut Options Held
2.6K-
Federated Hermes, Inc. Pittsburgh, PA3.6MShares$3.6 Million0.01% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$2.24 Million0.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$1.69 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.45MShares$1.45 Million0.13% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$555,5550.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $32.7M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...